These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 30610247

  • 1. Mucinous appendiceal neoplasms: classification, imaging, and HIPEC.
    Bartlett DJ, Thacker PG, Grotz TE, Graham RP, Fletcher JG, VanBuren WM, Iyer VR, Fidler JL, Menias CO, Wasif N, Sheedy SP.
    Abdom Radiol (NY); 2019 May; 44(5):1686-1702. PubMed ID: 30610247
    [Abstract] [Full Text] [Related]

  • 2. What is the optimum post treatment surveillance imaging protocol for low-grade appendiceal mucinous neoplasms and pseudomyxoma peritoneii?
    Dempsey PJ, Power JW, Yates AH, Martín-Román L, Aird JJ, Mulsow J, Fenlon HM, Cronin CG.
    Br J Radiol; 2024 Aug 01; 97(1160):1405-1412. PubMed ID: 38749003
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
    Lu YY, Guo AT, Liu AJ, Shi HY.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug 01; 48(8):595-601. PubMed ID: 24199925
    [Abstract] [Full Text] [Related]

  • 4. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
    Sugarbaker PH.
    Eur J Surg Oncol; 2017 Jun 01; 43(6):1083-1087. PubMed ID: 28131668
    [Abstract] [Full Text] [Related]

  • 5. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M.
    Ann Surg Oncol; 2018 Feb 01; 25(2):404-413. PubMed ID: 29159742
    [Abstract] [Full Text] [Related]

  • 6. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ.
    Eur J Surg Oncol; 2015 Mar 01; 41(3):396-9. PubMed ID: 25216980
    [Abstract] [Full Text] [Related]

  • 7. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
    Di Leo A, Corvasce A, Weindelmayer J, Mason EJ, Casella F, de Manzoni G.
    Updates Surg; 2020 Dec 01; 72(4):1207-1212. PubMed ID: 32410159
    [Abstract] [Full Text] [Related]

  • 8. A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
    Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF.
    Ann Surg Oncol; 2015 Oct 01; 22(11):3640-6. PubMed ID: 25698402
    [Abstract] [Full Text] [Related]

  • 9. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin.
    Munoz-Zuluaga CA, King MC, Ledakis P, Gushchin V, Sittig M, Nieroda C, Zambrano-Vera K, Sardi A.
    Eur J Surg Oncol; 2019 Sep 01; 45(9):1598-1606. PubMed ID: 31109821
    [Abstract] [Full Text] [Related]

  • 10. Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II).
    Parkin E, Selvasekar C, Wilson M, Renehan A, O'Dwyer S, Aziz O.
    Ann Surg Oncol; 2019 Jul 01; 26(7):2285. PubMed ID: 30989495
    [Abstract] [Full Text] [Related]

  • 11. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.
    Ann Surg Oncol; 2015 May 01; 22(5):1716-21. PubMed ID: 25145504
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Garach NR, Kusamura S, Guaglio M, Bartolini V, Deraco M, Baratti D.
    Eur J Surg Oncol; 2021 May 01; 47(5):1132-1139. PubMed ID: 33280949
    [Abstract] [Full Text] [Related]

  • 13. Psoas/iliacus muscle invasion from mucinous appendiceal neoplasm. Radiologic appearance and outcome of treatment in 3 patients.
    Sugarbaker PH.
    Surg Oncol; 2018 Jun 01; 27(2):154-157. PubMed ID: 29937165
    [Abstract] [Full Text] [Related]

  • 14. Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?
    Huang Y, Alzahrani NA, Liauw W, Traiki TB, Morris DL.
    Ann Surg Oncol; 2017 Jan 01; 24(1):176-183. PubMed ID: 27718032
    [Abstract] [Full Text] [Related]

  • 15. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.
    Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF.
    Ann Surg Oncol; 2017 Sep 01; 24(9):2646-2654. PubMed ID: 28695394
    [Abstract] [Full Text] [Related]

  • 16. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
    Marcotte E, Dubé P, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Sideris L.
    World J Surg Oncol; 2014 Nov 07; 12():332. PubMed ID: 25380618
    [Abstract] [Full Text] [Related]

  • 17. Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei.
    Liu Q, Jiao J, Li C, Chen Y, Wang B, Shi J, Yu G.
    World J Surg Oncol; 2024 May 21; 22(1):134. PubMed ID: 38769546
    [Abstract] [Full Text] [Related]

  • 18. Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).
    Barrios P, Losa F, Gonzalez-Moreno S, Rojo A, Gómez-Portilla A, Bretcha-Boix P, Ramos I, Torres-Melero J, Salazar R, Benavides M, Massuti T, Aranda E.
    Clin Transl Oncol; 2016 May 21; 18(5):437-48. PubMed ID: 26489426
    [Abstract] [Full Text] [Related]

  • 19. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y, Ishibashi H, Hirano M, Takeshita K, Mizumoto A, Ichinose M, Nishino E, Kashu I, Yamamoto Y, Sugarbaker PH, Yonemura Y.
    Ann Surg Oncol; 2015 Aug 21; 22(8):2799-805. PubMed ID: 25572681
    [Abstract] [Full Text] [Related]

  • 20. Association between preoperative appendiceal histology grade and Pseudomyxoma peritonei grade offers a solution to avoid right hemicolectomy during cytoreductive surgery and HIPEC.
    Ghandour R, Bardier A, Wagner M, Malgras B, Kaci R, Doat S, Pocard M.
    Surg Oncol; 2024 Oct 21; 56():102123. PubMed ID: 39163796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.